Read the Beforeitsnews.com story here. Advertise at Before It's News here.
Profile image
By Donald Marron (Reporter)
Contributor profile | More stories
Story Views
Now:
Last hour:
Last 24 hours:
Total:

Three Things You Should Know about the Buyback Furor

% of readers think this story is Fact. Add your two cents.


Record stock buybacks—driven in part by the corporate tax changes in the Tax Cuts and Jobs Act (TCJA)—have sparked a media and political furor. Unfortunately, they’ve also created a great deal of confusion. To help elevate the debate, here are three things you should know.

1. Repatriated overseas profits are the main way TCJA is boosting buybacks

By slashing corporate taxes, TCJA will boost after-tax profits and cash flow. Companies will use some of that cash to buy back shares. But that is not the main way TCJA is fueling today’s record buybacks.

The big reason is the “liberation” of around $3 trillion in overseas profits. Our old system taxed the earnings of foreign affiliates only when the domestic parent company made use of them. To avoid that tax, many companies left those earnings in their affiliates. They could reinvest them in their foreign operations or hold them in U.S. financial institutions and securities, but they couldn’t use them for dividends to parent company shareholders or stock buybacks.

By imposing a one-time tax on those accumulated profits, the TCJA freed companies to use the money wherever they wanted, including in the United States. And multinational firms are leaping at the chance. Cisco, for example, says they are repatriating $67 billion and buying back more than $25 billion in stock.

Cisco’s response reflects a broader trend. Repatriated profits will account for two-thirds of this year’s increase in stock buybacks, according to JP Morgan. Stronger earnings, due to both improved before-tax profits and lower taxes, make up only one-third.

2. Buybacks do not mechanically increase stock prices

Buybacks can help shareholders. But it’s not as simple as much commentary suggests.

The common story is that buybacks boost stock prices by reducing the number of shares outstanding. That sounds like basic economics: Reduce supply, increase price. But buybacks have a second effect that pushes the other way.

When companies pay out cash, their value falls. This effect is easy to see when companies pay dividends. On the morning after a dividend, a company’s stock price usually drops. One day the stock price reflects the company’ s operating value plus the cash it will use for the dividend. The next day it’s just the operating value.

That also happens when a company buys back stock. It spends its cash, so the value of each share declines. But this decline isn’t conspicuous. It doesn’t happen on an announced day (as with a dividend payment), and it happens at the same time the supply effect is pushing the other way. So commentators tend to overlook the stock price hit from cash going out the door.

How do the two effects net out? It depends. For starters, suppose we live in a frictionless (and mythical) world. There are no taxes, everybody is well informed, executives are perfect agents of shareholders, and it’s costless to raise new capital. In that world, the two effects exactly offset. The decline in the stock price from paying out cash matches the increase in the stock price from having fewer shares outstanding. And the stock price does not change.

In this world, a dollar on the company’s balance sheet has the same value for investors—one dollar—as a dollar on the investors’ own balance sheets. Stock buybacks simply move some dollars from the company to its investors. But they don’t create or destroy any value.

Of course, the real world isn’t frictionless. Taxes matter, as do imperfect information, misaligned incentives, and the cost of raising capital. The question is how do they matter. Is a dollar on a company’s balance sheet worth more than an investor’s dollar? Less? The same?

It depends. Suppose a company has many promising investment opportunities. If raising capital is expensive, a dollar inside the company may be worth more than a dollar outside. Investors value the ability to pursue good opportunities without the burden of raising new capital. In this case, a (misguided) stock buyback would drive the value of the stock down, not up.

Another company might have few promising investment opportunities. Shareholders might worry executives will squander extra cash, perhaps through empire building, executive perks, or just taking their eye off the ball. Investors might therefore treat a dollar of cash inside this company as worth less than a dollar, perhaps 90 cents or even as little as 40 cents. In these cases, stock buybacks would drive the value of the stock up.

On average, stock buybacks are more common in the second scenario than the first. So buybacks do tend to lift stock prices. Not because of the mechanical link between supply and price, but because shareholders value a dollar on their own balance sheets more than a dollar inside the companies buying back stock.

3. Today’s buyback furor reflects a much larger debate about shareholder capitalism.

Concern about buybacks didn’t start with the TCJA. Some commentators have long worried that shareholders can be shortsighted. They may focus too much on next quarter and too little on next decade. If so (there is much debate), shareholders may undervalue cash inside companies. Buybacks may thus be too large, hurting shareholders themselves and the broader economy.

Others object to shareholder capitalism more fundamentally. Comparing the value of dollars inside and outside a company presumes those dollars belong to shareholders. Our system largely works that way today. But what if workers and other stakeholders also have a claim? If so (again there is much debate), buybacks may allow shareholders to capture all the value from what should be shared resources. This concern animates Senator Cory Booker’s recent proposal to limit stock buybacks.

Evaluating these concerns is a job for another day. For now, remember that the stock buyback debate boils down to three basic questions. When do investors think money inside a company is less valuable than outside? How well do investors make that judgment? Should investors be the only ones with a claim on a company’s money? Debate over those questions will continue long after today’s focus on the TCJA.

This post originally appeared on TaxVox, the blog of the Tax Policy Center.


Source: https://dmarron.com/2018/04/12/three-things-you-should-know-about-the-buyback-furor/


Before It’s News® is a community of individuals who report on what’s going on around them, from all around the world.

Anyone can join.
Anyone can contribute.
Anyone can become informed about their world.

"United We Stand" Click Here To Create Your Personal Citizen Journalist Account Today, Be Sure To Invite Your Friends.

Lion’s Mane Mushroom Nootropic

Mushrooms are having a moment. One fabulous fungus in particular, lion’s mane, may help improve memory, depression and anxiety symptoms. They are also an excellent source of nutrients that show promise as a therapy for dementia, and other neurodegenerative diseases. If you’re living with anxiety or depression, you may be curious about all the therapy options out there — including the natural ones.Our Lion’s Mane WHOLE MIND Nootropic Blend has been formulated to utilize the potency of Lion’s mane but also include the benefits of four other Highly Beneficial Mushrooms. Synergistically, they work together to Build your health through improving cognitive function and immunity regardless of your age. Our Nootropic not only improves your Cognitive Function and Activates your Immune System, But it benefits growth of Essential Gut Flora, further enhancing your Vitality.



Our Formula includes: Lion’s Mane Mushrooms which Increase Brain Power through nerve growth, lessen anxiety, reduce depression, and improve concentration. Its an excellent adaptogen, promotes sleep and improves immunity.


Shiitake Mushrooms which Fight cancer cells and infectious disease, boost the immune system, promotes brain function, and serves as a source of B vitamins.


Maitake Mushrooms which regulate blood sugar levels of diabetics, reduce hypertension and boosts the immune system.


Reishi Mushrooms which Fight inflammation, liver disease, fatigue, tumor growth and cancer. They Improve skin disorders and soothes digestive problems, stomach ulcers and leaky gut syndrome.


Chaga Mushrooms which have anti-aging effects, boost immune function, improve stamina and athletic performance, even act as a natural aphrodisiac, fighting diabetes and improving liver function.


Try Our Lion’s Mane WHOLE MIND Nootropic Blend 60 Capsules Today. Be 100% Satisfied or Receive a Full Money Back Guarantee. Order Yours Today by Following This Link.

Report abuse

    Comments

    Your Comments
    Question   Razz  Sad   Evil  Exclaim  Smile  Redface  Biggrin  Surprised  Eek   Confused   Cool  LOL   Mad   Twisted  Rolleyes   Wink  Idea  Arrow  Neutral  Cry   Mr. Green

    MOST RECENT
    Load more ...

    SignUp

    Login

    Newsletter

    Email this story
    Email this story

    If you really want to ban this commenter, please write down the reason:

    If you really want to disable all recommended stories, click on OK button. After that, you will be redirect to your options page.